Paper36968618
Drug-induced liver injury: a comprehensive review.
Hosack T and 2 others. Ther Adv Gastroenterol, 2023. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. Drug-induced liver injury: a comprehensive review. Papers, record 36968618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22855883 | FDA summary of adverse events on electronic cigarettes. | Nicotine Tob Res | 2013 | https://conductscience.org/library/papers/22855883 | PubMed |
| 2 | 35656297 | N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35656297 | PubMed |
| 3 | 11866484 | Drug metabolism and drug interactions in the elderly. | Best Pract Res Clin Gastroenterol | 2001 | https://conductscience.org/library/papers/11866484 | PubMed |
| 4 | 29853659 | Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade. | Oncologist | 2018 | https://conductscience.org/library/papers/29853659 | PubMed |
| 5 | 8229111 | Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. | J Clin Epidemiol | 1993 | https://conductscience.org/library/papers/8229111 | PubMed |
| 6 | 28370205 | FABP1 as a novel potential biomarker for predicting mortality in acetaminophen-induced acute liver failure. | Hepatology | 2017 | https://conductscience.org/library/papers/28370205 | PubMed |
| 7 | 35243675 | Letter to the editor: Electronic RUCAM: Major pitfalls call for caution and proper validation. | Hepatology | 2022 | https://conductscience.org/library/papers/35243675 | PubMed |
| 8 | 31892250 | Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31892250 | PubMed |
| 9 | 27224670 | Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. | Liver Int | 2017 | https://conductscience.org/library/papers/27224670 | PubMed |
| 10 | 19475693 | Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. | Hepatology | 2009 | https://conductscience.org/library/papers/19475693 | PubMed |
| 11 | 28782153 | N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury. | Liver Int | 2018 | https://conductscience.org/library/papers/28782153 | PubMed |
| 12 | 28379596 | Liver transplantation for drug-induced acute liver failure. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28379596 | PubMed |
| 13 | 19826967 | Epidemiology of idiosyncratic drug-induced liver injury. | Semin Liver Dis | 2009 | https://conductscience.org/library/papers/19826967 | PubMed |
| 14 | 30022949 | Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30022949 | PubMed |
| 15 | 32768244 | Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development. | J Autoimmun | 2020 | https://conductscience.org/library/papers/32768244 | PubMed |
| 16 | 28440304 | The Natural History of Severe Acute Liver Injury. | Am J Gastroenterol | 2017 | https://conductscience.org/library/papers/28440304 | PubMed |
| 17 | 22931300 | Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. | Chem Res Toxicol | 2012 | https://conductscience.org/library/papers/22931300 | PubMed |
| 18 | 11172350 | A model to predict survival in patients with end-stage liver disease. | Hepatology | 2001 | https://conductscience.org/library/papers/11172350 | PubMed |
| 19 | 12143055 | Incidence of drug-induced hepatic injuries: a French population-based study. | Hepatology | 2002 | https://conductscience.org/library/papers/12143055 | PubMed |
| 20 | 8229110 | Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. | J Clin Epidemiol | 1993 | https://conductscience.org/library/papers/8229110 | PubMed |
Cited by113
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920164 | Epinephrine-mediated sensitization of thioredoxin 1 enhances chlorpromazine protection against acute hepatotoxicity. | BMC Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42920164 | PubMed |
| 42901497 | Hepatic Cysts in Korea: Prevalence, Incidence, and Risk Factors Based on a 5.8-Year Follow-up Health Screening Cohort. | J Korean Med Sci | 2026 | https://conductscience.org/library/papers/42901497 | PubMed |
| 42856423 | High-Throughput Morphological Profiling of Patient-Derived Human Liver Organoids for Hepatotoxicity Hazard Identification and Compound Prioritization. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856423 | PubMed |
| 42840333 | A pharmacist-led framework for antibiotic-associated liver injury: from pharmacovigilance signals to bedside surveillance with the updated RUCAM and susceptibility markers. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42840333 | PubMed |
| 42830472 | A multiparametric in vitro strategy for small molecule drug-induced liver injury risk mitigation in early drug development. | Toxicol Sci | 2026 | https://conductscience.org/library/papers/42830472 | PubMed |
| 42805974 | Risk of drug-induced liver injury in multiple system atrophy patients treated with KM-819 is potentially associated with the HLA-DPB1*05:01:01:01 allele. | Pharmacogenomics J | 2026 | https://conductscience.org/library/papers/42805974 | PubMed |
| 42797383 | Computational Prediction of the Severity of Adverse Drug Reactions Caused by Drug-Drug Interactions. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797383 | PubMed |
| 42768705 | Drug-Induced Liver Injury During Treatment With Tocilizumab: A Case Report of an Atypical Pattern Lesion. | Pharmacol Res Perspect | 2026 | https://conductscience.org/library/papers/42768705 | PubMed |
| 42731995 | In vitro approaches for modelling gut-liver crosstalk in drug-induced liver injury. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42731995 | PubMed |
| 42652215 | Dietary, Nutrient, and Supramolecular Nanofiber Modulation of the Liver Sinusoidal Clearance System in Metabolic Diseases and Aging. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652215 | PubMed |
| 42639177 | Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI). | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42639177 | PubMed |
| 42591220 | Polygonatum odoratum extract ameliorates acetaminophen-induced acute liver injury by modulating the gut-liver axis and remodeling microbial and ceramide metabolism to suppress hepatic ferroptosis: insights from multi-omics. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42591220 | PubMed |
| 42587752 | Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing. | Cells | 2026 | https://conductscience.org/library/papers/42587752 | PubMed |
| 42582612 | RUCAM-ascertained immunology and autoimmunity specifics of six idiosyncratic drug-induced liver injury types with refined classification: their individual complex molecular interplay. | Front Immunol | 2026 | https://conductscience.org/library/papers/42582612 | PubMed |
| 42524294 | Stepwise design and synthesis of red-emitting, reversible, HOCl chemosensors for monitoring the progression of drug-induced liver injury. | RSC Adv | 2026 | https://conductscience.org/library/papers/42524294 | PubMed |
| 42512832 | Etiology-Based Comparative Evaluation of Toxic Hepatitis in a Tertiary Referral Cohort: Drug-Induced, Herb-Induced, Mushroom Poisoning, and Other Toxic Exposures. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42512832 | PubMed |
| 42442117 | Targeted degradation of hepatic KEAP1 mitigates drug-induced liver injury via dual boosting NRF2 and PGAM5 signaling. | Redox Biol | 2026 | https://conductscience.org/library/papers/42442117 | PubMed |
| 42419714 | Context-Aware Multilevel Classification of Semantic Relations in Drug-Adverse Drug Reaction (ADR) Networks-Predicting Drug-Induced Liver Injury (DILI) as a Case Study. | Chem Res Toxicol | 2026 | https://conductscience.org/library/papers/42419714 | PubMed |
| 42257007 | Meropenem-Induced Possible Mixed Drug-Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016). | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42257007 | PubMed |
| 42244311 | [Differences in the mechanisms, diagnostic biomarkers, and therapeutic strategies of drug-induced liver injury caused by traditional Chinese and Western medicines]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42244311 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36968618
GET https://conductscience.org/api/papers/v1/36968618/references?page=2